Houman Ashrafian - Profile and Investment Details

Investor Profile

Houman Ashrafian is a Venture Capital, Investor based in Greater London, England, United Kingdom with a diverse investment portfolio that includes companies such as Enara Bio, Direct Flow Medical, Kesios Therapeutics, Pulmocide, myOrthos, CSA Medical, Avitide, Sutro Biopharma, CardioFocus, TopiVert, Aligned TeleHealth, LOQUS23 THERAPEUTICS, CytoMed Therapeutics, Bicycle Therapeutics, Jet Health, Centauri Health Solutions, PanOptica, Halscion, Inc., Urgent Team Holdings, Inc., Arsanis, Atopix Therapeutics, Bardy Diagnostics, EBT Medical, Cibiem, Inc., CardioKinetix, Amwell, Avrobio, NKT Therapeutics, Pionyr Immunotherapeutics, Healthify, Zarodex Therapeutics, Misonix, Sitryx Therapeutics, KalVista Pharmaceuticals, Good Start Genetics, Aerocare Holdings, Alchemab Therapeutics Ltd, Cerevance, Sitryx, Karus Therapeutics, Dementia Discovery Fund, Ribometrix, Transposon Therapeutics, Spinal Kinetics, Catamaran Bio, Zarodex Thereapeutics, Thesan Pharmaceuticals, Autifony Therapeutics, ReShape Lifesciences, Leiter's, Weatherden, Artios Pharma, TRex Bio, Endotronix, Maestro Health, EBR Systems, ValenTx, AllianceCareXilio Therapeutics, Karus Therapeutics Limited, Mestag Therapeutics, Evidation Health, SUN Behavioral Health, Caraway Therapeutics, Heart Metabolomics, Soffio Medical, Quell Therapeutics, Zerigo Health, VHSquared, AqueSys, Doctors of Physical Therapy, AcuFocus, Cellinta, Schweiger Dermatology, Deciphera Pharmaceuticals, Cardiac Report, Delenex Therapeutics, . Over time, Houman Ashrafian has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Houman Ashrafian is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Research and Development, Drug Discovery, Genetics, Wellness, Women Founded, Rare Diseases, Healthcare Innovation, Life Science, Emerging Markets, Health Technology, Information Services, Analytics, Diabetes, Business Development, Manufacturing, Biotechnology, Drug Development, Genomics, Innovation, Neuroscience, Clinical Trials, Digital Transformation, Research, Vaccines, Personalized Medicine, Mergers and Acquisitions, Health Diagnostics, Social Impact, UK-based Startups, Digital Health, Developer Tools, Renewable Energy, Medical, Big Data, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Personal Health, Pharmaceuticals, Healthcare Technology, Acquisitions, Oncology may find it worthwhile to explore potential connections with Houman Ashrafian, as their portfolio suggests a familiarity and interest in this area.

Understanding Houman Ashrafian’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.